Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway

por Alver, Tine Norman, Heintz, Karen‐Marie, Hovig, Eivind, Bøe, Sigurd L.
Publicado 2022

MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand NRG1-beta in melanoma

por Alver, Tine N., Lavelle, Timothy J., Longva, Ane S., Øy, Geir F., Hovig, Eivind, Bøe, Sigurd L.
Publicado 2016